These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32972909)

  • 1. Treatment of psoriasis vulgaris with guselkumab in a patient with non-small cell lung cancer.
    Kamiya K; Yamauchi H; Ohtsuki M
    Eur J Dermatol; 2020 Oct; 30(5):609-611. PubMed ID: 32972909
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis.
    Br J Dermatol; 2024 Jun; 191(1):e3. PubMed ID: 38900670
    [No Abstract]   [Full Text] [Related]  

  • 3. Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
    Kearney N; Kirby B
    Br J Dermatol; 2024 Jun; 191(1):5-6. PubMed ID: 38282352
    [No Abstract]   [Full Text] [Related]  

  • 4. Remarkable response to ixekizumab in a patient with generalized pustular psoriasis: a therapeutic challenge.
    Hsu HH; Wang HJ; Sun Y; Lan CC
    Ital J Dermatol Venerol; 2024 Jun; 159(3):373-374. PubMed ID: 38635325
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of acquired idiopathic generalized anhidrosis with perspiration maintained at sites of brodalumab injection to treat psoriasis vulgaris.
    Mikoshiba A; Katsuie S; Satake K; Kitamura S; Sato Y; Kiniwa Y; Sano K; Okuyama R
    J Dermatol; 2024 May; 51(5):e160-e161. PubMed ID: 38009840
    [No Abstract]   [Full Text] [Related]  

  • 6. Dramatic early improvement of psoriasis in an 11-year old boy after four doses of secukinumab following an alternative dosing scheme.
    Hoff J; Spora L; Fang Y; Brüggen MC; Möhrenschlager M
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e399-e400. PubMed ID: 37909322
    [No Abstract]   [Full Text] [Related]  

  • 7. Spesolimab: Is it a new treatment target in palmoplantar pustulosis?
    Huang H; Zhang Y; Wu Y; Li C
    Int J Rheum Dis; 2024 May; 27(5):e15154. PubMed ID: 38720596
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of guselkumab on three cases of SSc accompanying psoriasis.
    Fukasawa T; Yoshizaki-Ogawa A; Yoshizaki A; Sato S
    Rheumatology (Oxford); 2024 Jan; 63(1):e6-e8. PubMed ID: 37310917
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
    Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dtsch Dermatol Ges; 2024 May; 22(5):713-715. PubMed ID: 38593343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research of Cognitive Impairment in Lung Cancer Patients Undergoing Chemotherapy].
    Kumano K; Oishi A; Matsuda N; Nakano T; Kamimura A; Shindo A; Kido K; Yamada T
    Gan To Kagaku Ryoho; 2023 Sep; 50(9):1013-1015. PubMed ID: 37800300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the vestibulo-spinal system with a five-dimensional feedback model.
    Tokita T; Takagi K; Ito Y
    Acta Otolaryngol; 1987; 104(3-4):322-7. PubMed ID: 3499744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1).
    Imafuku S; Nakagawa H; Igarashi A; Morita A; Okubo Y; Sano S; Tada Y; Nemoto O; Rozzo SJ; Kawamura M; Ohtsuki M
    J Dermatol; 2021 Jun; 48(6):844-852. PubMed ID: 33523513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
    Thein KZ; Karp DD; Tsimberidou A; Gong J; Sulovic S; Shah J; Milton DR; Hong DS; Janku F; McQuinn L; Stephen BA; Colen R; Carter BW; Yap TA; Piha-Paul SA; Fu S; Meric-Bernstam F; Naing A
    Invest New Drugs; 2022 Apr; 40(2):290-299. PubMed ID: 34562230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
    Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
    Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the 'CROSS-regimen' in daily practice.
    Cloos-V Balen M; Portier ESH; Fiocco M; Hartgrink HH; Langers AMJ; Neelis KJ; Lips IM; Peters FP; Slingerland M
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34557905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once- Versus Twice-Daily Angiotensin-Converting Enzyme Inhibitors for Blood Pressure Control in Adult Patients With Hypertension.
    Fischer K; Diec S
    Cureus; 2021 Aug; 13(8):e17331. PubMed ID: 34567875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring and Rituximab treatment in insulin autoimmune syndrome.
    Boro H; Gupta U; Singh C; Malhotra R; Khadgawat R
    Diabetes Metab Syndr; 2021; 15(6):102294. PubMed ID: 34562871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
    Dev R; Zhong LL; Zarifa A; Albittar AA; Rubin L; Liu S; Yap TA; Dalal S; Hui D; Karp DD; Tsimberidou AM; Piha-Paul SA; Ahnert JR; Fu S; Meric-Bernstam F; Naing A
    Invest New Drugs; 2022 Feb; 40(1):124-133. PubMed ID: 34559346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms.
    Gupta A; Nshuti L; Grewal US; Sedhom R; Check DK; Parsons HM; Blaes AH; Virnig BA; Lustberg MB; Subbiah IM; Nipp RD; Dy SM; Dusetzina SB
    JCO Oncol Pract; 2022 Feb; 18(2):140-147. PubMed ID: 34558297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A hypothesis.
    Kaur J; Gulati M; Gowthamarajan K; Vishwas S; Kumar Chellappan D; Gupta G; Dua K; Pandey NK; Kumar B; Singh SK
    Med Hypotheses; 2021 Nov; 156():110679. PubMed ID: 34555619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.